Results 11 to 20 of about 12,753 (177)

Hyperphosphatemia and Cardiovascular Disease [PDF]

Frontiers in Cell and Developmental Biology, 2021
Hyperphosphatemia or even serum phosphate levels within the “normal laboratory range” are highly associated with increased cardiovascular disease risk and mortality in the general population and patients suffering from chronic kidney disease (CKD). As the kidney function declines, serum phosphate levels rise and subsequently induce the development of ...
Chao Zhou, Zhengyu Shi, Nan Ouyang, Xiongzhong Ruan, Xiongzhong Ruan   +4 more
openaire   +3 more sources

EOS789, pan‐phosphate transporter inhibitor, ameliorates the progression of kidney injury in anti‐GBM‐induced glomerulonephritis rats

Pharmacology Research & Perspectives, 2022
Hyperphosphatemia associated with chronic kidney disease (CKD) not only dysregulates mineral metabolism and bone diseases, but also strongly contributes to the progression of kidney disease itself.
Yoshinori Tsuboi, Yasuhiro Ichida, Atsuko Murai, Akira Maeda, Manami Iida, Atsuhiko Kato, Shuichi Ohtomo, Naoshi Horiba   +7 more
doaj   +1 more source

Psödohipoparatiroidi Tip 2: Olgu Sunumu

Genel Tıp Dergisi, 2021
Psödohipoparatiroidi, parathormona karşı hedef organ düzeyinde cevapsızlık nedeniyle hipokalsemi ve hiperfosfatemi gelişmesiyle karakterize bir bozukluktur.
Özlem Güleç Şen, Emre Kaçar, Tolga Altuğ Şen   +2 more
doaj   +1 more source

Hyperphosphatemia is associated with high mortality in severe burns. [PDF]

PLoS ONE, 2018
Phosphate level is often deranged during acute illness, regardless of the presence of kidney injury or not. A few studies described that hypophosphatemia may associated with outcome in patients admitted to the burn unit, but the literatures for ...
George Kuo, Cheng-Chia Lee, Shih-Yi Yang, Yen-Chang Hsiao, Shiow-Shuh Chuang, Su-Wei Chang, Kun-Hua Tu, Pei-Chun Fan, Ya-Chung Tian, Yung-Chang Chen, Chih-Hsiang Chang   +10 more
doaj   +1 more source

Phosphate Absorption and Hyperphosphatemia Management in Kidney Disease: A Physiology-Based Review

Kidney Medicine, 2021
Phosphate absorption occurs in the gastrointestinal tract through paracellular absorption and transcellular transport. The paracellular pathway does not saturate and has a significantly higher absorption capacity than does the transcellular pathway ...
Steven N. Fishbane, Sagar Nigwekar
doaj   +1 more source

Dose-Response of Tenapanor in Patients With Hyperphosphatemia Undergoing Hemodialysis in Japan—A Phase 2 Randomized Trial

Kidney International Reports, 2022
Introduction: Simplified, but effective, hyperphosphatemia treatments with novel mechanisms of action, tolerable safety profiles, and low pill burden are needed for patients undergoing hemodialysis.
Masaaki Inaba, Yotaro Une, Kazuaki Ikejiri, Hironori Kanda, Masafumi Fukagawa, Tadao Akizawa   +5 more
doaj   +1 more source

Pseudohyperphosphatemia resulting from hyperlipoproteinemia

Endocrinology Research and Practice, 2022
We report two patients whose serum samples presented severe hyperphosphatemia due to their high blood lipid levels. The patients had no clinical complaints owing to hyperphosphatemia, and there was no other reason to explain these patients' hyperphosph ...
Tamer Tetiker
doaj   +2 more sources

Research advances on the pathogenesis of vascular calcification caused by hyperphosphatemia associated with chronic kidney disease

Linchuang shenzangbing zazhi
Phosphorus is one of essential nutrients for the human body that plays an indispensable role in various physiological processes. The balance of blood phosphorus is crucial in all living organisms.
Wang Yu-han, Su Ji-li, Zhou Xiao-shuang
doaj   +3 more sources

The Relationship between Knowledge about Phosphorus, Dietary Phosphorus Intake and Serum Phosphorus Level in Maintenance Hemodialysis Patients

Journal of High Institute of Public Health, 2022
Background: Renal diet knowledge -especially phosphorus knowledge- is generally poor in Maintenance Hemodialysis (MHD) patients due to the complexity of information about dietary phosphorus thus causing poor compliance to dietary phosphorus guidelines ...
Rana H. Emara, Doha M. Abo Zahra
doaj   +1 more source

Hyperphosphatemia Management in Patients with Chronic Kidney Disease

Saudi Pharmaceutical Journal, 2015
Hyperphosphatemia in chronic kidney disease (CKD) patients is a potentially life altering condition that can lead to cardiovascular calcification, metabolic bone disease (renal osteodystrophy) and the development of secondary hyperparathyroidism (SHPT ...
Ahmed M. Shaman, Stefan R. Kowalski
doaj   +1 more source